Literature DB >> 12594065

Polymorphisms in the IL13, IL13RA1, and IL4RA genes and rate of decline in lung function in smokers.

Jian-Qing He1, John E Connett, Nicholas R Anthonisen, Andrew J Sandford.   

Abstract

Targeted expression of interleukin (IL)-13 in the adult murine lung has been shown to cause emphysema. We hypothesized that variants in the IL13, IL13RA1, and IL4RA genes would be associated with an accelerated rate of decline of lung function among smokers. We determined the allele frequencies of five polymorphisms in the IL13, IL13RA1, and IL4RA genes in 588 continuing smokers chosen from the NHLBI Lung Health Study for having the fastest (n = 282) and slowest (n = 306) 5-yr rate of decline of lung function (mean change in FEV(1) %predicted/yr = -4.1 and +1.1, respectively). The IL4RA 551RR genotype was associated with rapid decline of lung function (odds ratio, 2.24; P = 0.043). However, none of the other four polymorphisms was associated with rate of decline in lung function. The association of 551RR with rapid decline of lung function became more significant in subjects who also had either the IL13 130RR or -1112TT genotypes. However, because multiple comparisons were made and only a few individuals had the 551RR genotype, these associations may represent type 1 error. Haplotypes consisting of alleles from the IL13 polymorphisms or from the IL4RA polymorphisms were not associated with rate of decline in lung function in smokers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594065     DOI: 10.1165/rcmb.4885

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  12 in total

Review 1.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.

Authors:  Ann G Schwartz; John C Ruckdeschel
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

Review 2.  Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.

Authors:  Craig P Hersh
Journal:  Pharmacogenomics       Date:  2010-02       Impact factor: 2.533

3.  Associations of IL6 polymorphisms with lung function decline and COPD.

Authors:  J-Q He; M G Foreman; K Shumansky; X Zhang; L Akhabir; D D Sin; S F P Man; D L DeMeo; A A Litonjua; E K Silverman; J E Connett; N R Anthonisen; R A Wise; P D Paré; A J Sandford
Journal:  Thorax       Date:  2009-04-08       Impact factor: 9.139

4.  Decreased expression of interleukin 13 in human lung emphysema.

Authors:  A Boutten; M Bonay; S Laribe; G Leseche; Y Castier; V Leçon-Malas; M Fournier; G Durand; M Aubier; M Dehoux; B Crestani
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 5.  Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors:  Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

6.  Genome-wide study identifies two loci associated with lung function decline in mild to moderate COPD.

Authors:  Nadia N Hansel; Ingo Ruczinski; Nicholas Rafaels; Don D Sin; Denise Daley; Alla Malinina; Lili Huang; Andrew Sandford; Tanda Murray; Yoonhee Kim; Candelaria Vergara; Susan R Heckbert; Bruce M Psaty; Guo Li; W Mark Elliott; Farzian Aminuddin; Josée Dupuis; George T O'Connor; Kimberly Doheny; Alan F Scott; H Marike Boezen; Dirkje S Postma; Joanna Smolonska; Pieter Zanen; Firdaus A Mohamed Hoesein; Harry J de Koning; Ronald G Crystal; Toshiko Tanaka; Luigi Ferrucci; Edwin Silverman; Emily Wan; Jorgen Vestbo; David A Lomas; John Connett; Robert A Wise; Enid R Neptune; Rasika A Mathias; Peter D Paré; Terri H Beaty; Kathleen C Barnes
Journal:  Hum Genet       Date:  2012-09-18       Impact factor: 4.132

7.  Interferon gamma polymorphisms and their interaction with smoking are associated with lung function.

Authors:  Jian-Qing He; Kelly Burkett; John E Connett; Nicholas R Anthonisen; Peter D Paré; Andrew J Sandford
Journal:  Hum Genet       Date:  2006-02-11       Impact factor: 4.132

Review 8.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

9.  An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.

Authors:  Sandra Grumelli; David B Corry; Li-Zhen Song; Ling Song; Linda Green; Joseph Huh; Joan Hacken; Rafael Espada; Remzi Bag; Dorothy E Lewis; Farrah Kheradmand
Journal:  PLoS Med       Date:  2004-10-19       Impact factor: 11.069

10.  Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma.

Authors:  Raffi Tachdjian; Clinton Mathias; Shadi Al Khatib; Paul J Bryce; Hong S Kim; Frank Blaeser; Brian D O'Connor; Danuta Rzymkiewicz; Andrew Chen; Michael J Holtzman; Gurjit K Hershey; Holger Garn; Hani Harb; Harald Renz; Hans C Oettgen; Talal A Chatila
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.